The Guttmacher Institute has taken a stance on access to mifepristone via telehealth. They have joined two amicus briefs that call on the Supreme Court to protect this access. Further details on this development are available from the institute. The action was announced in a news release on May 11, 2026. More information can be found through the Guttmacher Institute, including a link to the full news release and related social media posts.
politics
The Guttmacher Institute and Its Scientists Join Two Amicus Briefs Calling on the Supreme Court to Protect Access to Mifepristone via Telehealth
The Guttmacher Institute has taken a stance on access to mifepristone via telehealth. They have joined two amicus briefs that call on the Supreme Court to protect this access. Further details on this
